NCT06117085
- Conditions
- Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +6 more
- Locations
-
- Ospedale del Mare | ASLNA1 Centro Naples, Italy
Clinical trial condition
Endocrine Gland Neoplasms
Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.
6,117 public trials
1,368 recruiting studies
Endocrine Gland Neoplasms trial results
NCT03159572
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
- Locations
-
- Niigata University Graduate School of Medical and Dental Sciences Niigata, Japan
NCT02054351
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- UZ Brussels Brussels, Belgium
- UZ Leuven Leuven, Belgium
- Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg, Universitätsklinikum Heidelberg Heidelberg, Baden-Wurttemberg, Germany
- Universitäts-Frauenklinik (UFK) Tübingen Tübingen, Baden-Wurttemberg, Germany
NCT00739453
- Conditions
- Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +29 more
- Locations
-
- University of Colorado Health Science Center Aurora, Colorado, United States
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
- Hudson-Webber Cancer Research Center, Karmanos Cancer Institute Detroit, Michigan, United States
- University of Oxford Department of Medical Oncology Oxford, United Kingdom
Completed
A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma
NCT00924989
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +11 more
- Locations
-
- TGen Clinical Research Service at Scottsdale Healthcare Scottsdale, Arizona, United States
- University of Southern California Los Angeles, California, United States
- UCLA Los Angeles, California, United States
- University of Colorado Denver Cancer Center Aurora, Colorado, United States
Completed
Study of Continuous OSI-906 Dosing
NCT00514007
- Conditions
- Adnexal Diseases, Advanced Solid Tumors, Breast Diseases, +43 more
- Locations
-
- Vanderbilt Universtiy Medical Center Nashville, Tennessee, United States
- The Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
NCT00889382
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
- Locations
-
- Mayo Clinic Scottsdale, Arizona, United States
- Department of Obstetrics and Gynecology, University of California, Irvine Orange, California, United States
- Horizon Oncology Center Lafayette, Indiana, United States
- Ochsner Clinic Foundation New Orleans, Louisiana, United States
NCT06697613
- Conditions
- AKI - Acute Kidney Injury, Acute Kidney Injury, Adnexal Diseases, +19 more
- Locations
-
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Guangzhou, Guangdong, China
Completed
Study of Intermittent OSI-906 Dosing
NCT00514306
- Conditions
- Adnexal Diseases, Advanced Solid Tumors, Breast Diseases, +43 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
- Drug Development Unit, Royal Marsden Hospital Sutton, Surrey, United Kingdom
NCT03225989
- Conditions
- Adnexal Diseases, Biliary Carcinoma, Colonic Diseases, +25 more
- Locations
-
- Karolinska University Hospital, Huddinge Stockholm, Sweden
- Uppsala University Hospital Uppsala, Sweden